By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s insulin formulation portfolio, featuring four clinical-stage products and one preclinical product, is among the largest and most differentiated in the industry.

YEAR FOUNDED:

December 2005

LEADERSHIP:

Founders: Gérard Soula, Olivier Soula, and Rémi Soula

CEO: Gérard Soula

CFO: Valérie Danaguezian

JOBS:

Please click here for Adocia job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Adocia
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia Announces Its Revenue And Cash Position For 2016 2/14/2017 11:23:19 AM
Adocia To Present At The Leerink Partners 6th Annual Global Healthcare Conference 2/13/2017 12:19:30 PM
Eli Lilly (LLY) Bails Out of Ultra-Rapid Insulin Deal With Adocia 1/27/2017 5:36:03 AM
Adocia To Hold Conference Call Providing An Update On Its Programs 1/25/2017 10:46:26 AM
Adocia And Eli Lilly (LLY) Announce Successful Completion Of An Insulin Pump Study With Biochaperone Lispro In People With Type 1 Diabetes 12/19/2016 8:57:37 AM
Adocia Receives The 1st Prize For "Profitable Growth" And The 3rd "Technology Fast 50" Prize As Part Of The 2016 Deloitte In Extenso Technology Fast 50 Grand Rhône Alpes 11/8/2016 9:37:58 AM
Adocia Announces Positive Topline Results From A Phase 1b Clinical Trial Measuring The Post-Meal Effect Of Rapid-Acting Human Insulin, Hinsbet U100 10/31/2016 3:17:58 PM
Adocia Announces Third Quarter 2016 Financial Results 10/13/2016 9:23:29 AM
Adocia Received The EY Global Company Award For The Auvergne Rhône-Alpes Region 9/22/2016 11:22:11 AM
Adocia Announces New BioChaperone Program Combining A Basal Insulin And GLP-1s 9/14/2016 9:19:39 AM
1234567
//-->